{"id":3994,"date":"2026-01-29T11:56:25","date_gmt":"2026-01-29T11:56:25","guid":{"rendered":"https:\/\/oportoaccounting.com\/?p=3994"},"modified":"2026-02-23T16:55:52","modified_gmt":"2026-02-23T16:55:52","slug":"step-business-rdi-digital-biotechnology","status":"publish","type":"post","link":"https:\/\/oportoaccounting.com\/new\/2026\/01\/29\/step-business-rdi-digital-biotechnology\/","title":{"rendered":"STEP Business R&#038;D&#038;I for Digital and Biotechnology"},"content":{"rendered":"<p>[et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_row _builder_version=&#8221;4.16&#8243; background_size=&#8221;initial&#8221; background_position=&#8221;top_left&#8221; background_repeat=&#8221;repeat&#8221; width=&#8221;79.8%&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; custom_padding=&#8221;|||&#8221; global_colors_info=&#8221;{}&#8221; custom_padding__hover=&#8221;|||&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; background_size=&#8221;initial&#8221; background_position=&#8221;top_left&#8221; background_repeat=&#8221;repeat&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p data-start=\"669\" data-end=\"879\">STEP Business R&amp;D&amp;I for Digital and Biotechnology supports integrated research, development and productive innovation projects focused on the development, scale-up and commercial production of critical digital and biotechnology technologies. In doing so, it reinforces strategic European value chains through consortia led by companies under the EU Strategic Technologies for Europe Platform (STEP).<\/p>\n<p data-start=\"669\" data-end=\"879\">\n<h3 data-start=\"881\" data-end=\"1231\">Programme details<\/h3>\n<ul>\n<li data-start=\"1286\" data-end=\"1326\">\n<p data-start=\"1288\" data-end=\"1326\"><strong data-start=\"1288\" data-end=\"1313\">Application deadline:<\/strong><em>30 April 2026<\/em><\/p>\n<\/li>\n<li data-start=\"1327\" data-end=\"1410\">\n<p data-start=\"1329\" data-end=\"1410\"><strong data-start=\"1329\" data-end=\"1354\">Beneficiary entities:<\/strong> Large companies, SMEs, micro-enterprises and startups (in co-promotion consortia)<\/p>\n<\/li>\n<li data-start=\"1470\" data-end=\"1531\">\n<p data-start=\"1472\" data-end=\"1531\"><strong data-start=\"1472\" data-end=\"1484\">Benefit:<\/strong> R&amp;D activities: up to 80% funding and productive innovation activities: up to 70% funding, in accordance with regional aid maps and State aid rules.<\/p>\n<\/li>\n<li data-start=\"1470\" data-end=\"1531\"><strong>Minimum investment:<\/strong> \u20ac5,000,000<\/li>\n<li data-start=\"1575\" data-end=\"1642\">\n<p data-start=\"1577\" data-end=\"1642\"><strong data-start=\"1577\" data-end=\"1598\">Geographic scope: Mainland Portugal (excluding Lisbon area)<\/strong><\/p>\n<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<h2 data-start=\"1649\" data-end=\"1670\"><strong>About the funding<\/strong><\/h2>\n<p><strong><\/strong><\/p>\n<p data-start=\"313\" data-end=\"478\"><a href=\"https:\/\/eur-lex.europa.eu\/PT\/legal-content\/summary\/strategic-technologies-for-europe-platform-step.html\">STEP Business R&amp;D&amp;I for Digital and Biotechnology <\/a>supports integrated investment operations combining industrial research, experimental development and productive innovation.<\/p>\n<p data-start=\"1330\" data-end=\"1571\">Projects must target higher Technology Readiness Levels (TRL \u2265 6), with limited activities allowed from TRL 4. The programme is designed to accelerate the transition from advanced development to industrial deployment and market introduction.<\/p>\n<p data-start=\"1573\" data-end=\"1731\">Eligible operations must contribute to the development, manufacturing or reinforcement of value chains of critical technologies in one of the following areas:<\/p>\n<ul>\n<li data-start=\"1733\" data-end=\"1909\">Digital technologies, including deep tech and technologies aligned with the Digital Decade objectives<\/li>\n<li data-start=\"1733\" data-end=\"1909\">Biotechnologies, including critical medicines and their components<\/li>\n<\/ul>\n<p data-start=\"1911\" data-end=\"2082\">Projects must align with STEP objectives, demonstrate innovation or strategic value-chain reinforcement, and lead to commercialisation or industrial deployment of results.<\/p>\n<p data-start=\"2084\" data-end=\"2126\"><strong>The maximum project duration is 36 months.<\/strong><\/p>\n<p data-start=\"804\" data-end=\"964\">\n<h3 data-start=\"1943\" data-end=\"1974\"><strong data-start=\"1946\" data-end=\"1974\">How it works<\/strong><\/h3>\n<p data-start=\"2147\" data-end=\"2309\">This grant requires the creation of co-promotion consortia led by companies and integrates both R&amp;D and productive investment components within a single operation.<\/p>\n<p data-start=\"2311\" data-end=\"2337\">Projects must demonstrate:<\/p>\n<ul>\n<li data-start=\"2339\" data-end=\"2407\">Strategic relevance within European critical technology priorities<\/li>\n<li data-start=\"2409\" data-end=\"2471\">Technological maturity compatible with industrial deployment<\/li>\n<li data-start=\"2473\" data-end=\"2542\">Clear contribution to competitiveness and value-chain strengthening<\/li>\n<li data-start=\"2544\" data-end=\"2634\">Market-oriented outcomes resulting in commercial production or industrial implementation<\/li>\n<\/ul>\n<p data-start=\"2636\" data-end=\"2795\">The integrated structure allows companies to combine research and development efforts with investment in production capacity within the same funding framework.<\/p>\n<p data-start=\"1487\" data-end=\"1611\">\n<p data-start=\"1487\" data-end=\"1611\">\n<p data-start=\"1487\" data-end=\"1611\">\n<h3 data-start=\"2697\" data-end=\"2725\"><\/h3>\n<h2 data-start=\"1551\" data-end=\"1586\"><strong data-start=\"1554\" data-end=\"1586\">Eligible investment expenses<\/strong><\/h2>\n<p data-start=\"2832\" data-end=\"2846\">R&amp;D component:<\/p>\n<ul>\n<li data-start=\"2848\" data-end=\"3352\">Personnel costs (technical staff, researchers, fellows)<\/li>\n<li data-start=\"2848\" data-end=\"3352\">Acquisition and licensing of patents<\/li>\n<li data-start=\"2848\" data-end=\"3352\">Consumables and raw materials<\/li>\n<li data-start=\"2848\" data-end=\"3352\">Prototypes, pilot and demonstration components<\/li>\n<li data-start=\"2848\" data-end=\"3352\">External scientific, technical and consultancy services<\/li>\n<li data-start=\"2848\" data-end=\"3352\">Equipment, scientific instruments and specialised software (amortisation)<\/li>\n<li data-start=\"2848\" data-end=\"3352\">Intellectual property protection costs<\/li>\n<li data-start=\"2848\" data-end=\"3352\">Dissemination of results (non-commercial)<\/li>\n<li data-start=\"2848\" data-end=\"3352\">Travel strictly related to R&amp;D<\/li>\n<li data-start=\"2848\" data-end=\"3352\">Certification, audits and financial validation costs<\/li>\n<\/ul>\n<p data-start=\"3354\" data-end=\"3386\">Productive innovation component:<\/p>\n<ul>\n<li data-start=\"3388\" data-end=\"3722\">Machinery and equipment<\/li>\n<li data-start=\"3388\" data-end=\"3722\">Tangible and intangible assets, including patents, licences, know-how and software<\/li>\n<li data-start=\"3388\" data-end=\"3722\">Engineering services, studies, audits and technical services (for SMEs)<\/li>\n<li data-start=\"3388\" data-end=\"3722\">Construction or refurbishment of facilities, within defined percentage limits<\/li>\n<li data-start=\"3388\" data-end=\"3722\">Job creation costs, as an alternative in eligible regions<\/li>\n<\/ul>\n<p data-start=\"3724\" data-end=\"3846\">All expenses must be directly related to the approved project and comply with applicable regional aid and State aid rules.<\/p>\n<p data-start=\"1910\" data-end=\"2054\">\n<p data-start=\"1910\" data-end=\"2054\">\n<h3 data-start=\"3976\" data-end=\"4010\"><\/h3>\n<h2 data-start=\"3976\" data-end=\"4010\"><strong>Who can benefit from this incentive<\/strong><\/h2>\n<p data-start=\"3890\" data-end=\"4054\">This incentive is aimed at companies developing critical technologies within digital and biotechnology sectors, operating through structured co-promotion consortia.<\/p>\n<p data-start=\"4056\" data-end=\"4107\">It is particularly relevant for organisations that:<\/p>\n<ul>\n<li data-start=\"4109\" data-end=\"4183\">Develop advanced technological solutions approaching industrial maturity<\/li>\n<li data-start=\"4185\" data-end=\"4237\">Require scale-up investment linked to R&amp;D outcomes<\/li>\n<li data-start=\"4239\" data-end=\"4287\">Operate within strategic European value chains<\/li>\n<li data-start=\"4289\" data-end=\"4359\">Intend to move from development stages to full industrial deployment<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p data-start=\"4168\" data-end=\"4316\">Understanding the rules and eligibility criteria of each incentive is essential to assess its relevance and potential impact within a company\u2019s broader investment and tax strategy.<br data-start=\"475\" data-end=\"478\" \/>For clarification or further information, <strong data-start=\"534\" data-end=\"572\">reach out through our <a href=\"https:\/\/oportoaccounting.com\/contacts\/\">contact form<\/a><\/strong>.<\/p>\n<p data-start=\"4168\" data-end=\"4316\">\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>[et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_row _builder_version=&#8221;4.16&#8243; background_size=&#8221;initial&#8221; background_position=&#8221;top_left&#8221; background_repeat=&#8221;repeat&#8221; width=&#8221;79.8%&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; custom_padding=&#8221;|||&#8221; global_colors_info=&#8221;{}&#8221; custom_padding__hover=&#8221;|||&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; background_size=&#8221;initial&#8221; background_position=&#8221;top_left&#8221; background_repeat=&#8221;repeat&#8221; global_colors_info=&#8221;{}&#8221;] STEP Business R&amp;D&amp;I for Digital and Biotechnology supports integrated research, development and productive innovation projects focused on the development, scale-up and commercial production of critical digital and biotechnology technologies. In doing so, it reinforces strategic European value chains through consortia led by companies under the EU Strategic Technologies for Europe Platform (STEP). Programme details Application deadline:30 April 2026 Beneficiary entities: Large companies, SMEs, micro-enterprises and startups (in co-promotion consortia) Benefit: R&amp;D activities: up to 80% funding and productive innovation activities: up to 70% funding, in accordance with regional aid maps and State aid rules. Minimum investment: \u20ac5,000,000 Geographic scope: Mainland Portugal (excluding Lisbon area) &nbsp; About the funding STEP Business R&amp;D&amp;I for Digital and Biotechnology supports integrated investment operations combining industrial research, experimental development and productive innovation. Projects must target higher Technology Readiness Levels (TRL \u2265 6), with limited activities allowed from TRL 4. The programme is designed to accelerate the transition from advanced development to industrial deployment and market introduction. Eligible operations must contribute to the development, manufacturing or reinforcement of value chains of critical technologies in one of the following areas: Digital technologies, including deep tech and technologies aligned with the Digital Decade objectives Biotechnologies, including critical medicines and their components Projects must align with STEP objectives, demonstrate innovation or strategic value-chain reinforcement, and lead to commercialisation or industrial deployment of results. The maximum project duration is 36 months. How it works This grant requires the creation of co-promotion consortia led by companies and integrates both R&amp;D and productive investment components within a single operation. Projects must demonstrate: Strategic relevance within European critical technology priorities Technological maturity compatible with industrial deployment Clear contribution to competitiveness and value-chain strengthening Market-oriented outcomes resulting in commercial production or industrial implementation The integrated structure allows companies to combine research and development efforts with investment in production capacity within the same funding framework. Eligible investment expenses R&amp;D component: Personnel costs (technical staff, researchers, fellows) Acquisition and licensing of patents Consumables and raw materials Prototypes, pilot and demonstration components External scientific, technical and consultancy services Equipment, scientific instruments and specialised software (amortisation) Intellectual property protection costs Dissemination of results (non-commercial) Travel strictly related to R&amp;D Certification, audits and financial validation costs Productive innovation component: Machinery and equipment Tangible and intangible assets, including patents, licences, know-how and software Engineering services, studies, audits and technical services (for SMEs) Construction or refurbishment of facilities, within defined percentage limits Job creation costs, as an alternative in eligible regions All expenses must be directly related to the approved project and comply with applicable regional aid and State aid rules. Who can benefit from this incentive This incentive is aimed at companies developing critical technologies within digital and biotechnology sectors, operating through structured co-promotion consortia. It is particularly relevant for organisations that: Develop advanced technological solutions approaching industrial maturity Require scale-up investment linked to R&amp;D outcomes Operate within strategic European value chains Intend to move from development stages to full industrial deployment &nbsp; Understanding the rules and eligibility criteria of each incentive is essential to assess its relevance and potential impact within a company\u2019s broader investment and tax strategy.For clarification or further information, reach out through our contact form. [\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"author":10,"featured_media":3961,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_monsterinsights_skip_tracking":false,"_uf_show_specific_survey":0,"_uf_disable_surveys":false,"footnotes":""},"categories":[38],"tags":[],"class_list":["post-3994","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-grants"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>STEP business R&amp;D&amp;I for digital and biotechnology<\/title>\n<meta name=\"description\" content=\"STEP business R&amp;D&amp;I supports integrated R&amp;D and innovation projects in digital, deep-tech and biotechnology sectors.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/oportoaccounting.com\/new\/2026\/01\/29\/step-business-rdi-digital-biotechnology\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"STEP business R&amp;D&amp;I for digital and biotechnology\" \/>\n<meta property=\"og:description\" content=\"STEP business R&amp;D&amp;I supports integrated R&amp;D and innovation projects in digital, deep-tech and biotechnology sectors.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/oportoaccounting.com\/new\/2026\/01\/29\/step-business-rdi-digital-biotechnology\/\" \/>\n<meta property=\"og:site_name\" content=\"Oporto Accounting\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/307331302463467\" \/>\n<meta property=\"article:published_time\" content=\"2026-01-29T11:56:25+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-23T16:55:52+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/oportoaccounting.com\/new\/wp-content\/uploads\/2026\/01\/2030-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"970\" \/>\n\t<meta property=\"og:image:height\" content=\"550\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"marketing@oportoaccounting.eu\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@OportoAccountin\" \/>\n<meta name=\"twitter:site\" content=\"@OportoAccountin\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"marketing@oportoaccounting.eu\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/oportoaccounting.com\/new\/2026\/01\/29\/step-business-rdi-digital-biotechnology\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/oportoaccounting.com\/new\/2026\/01\/29\/step-business-rdi-digital-biotechnology\/\"},\"author\":{\"name\":\"marketing@oportoaccounting.eu\",\"@id\":\"https:\/\/oportoaccounting.com\/new\/#\/schema\/person\/7252c4f13da985cd488664b8e798256f\"},\"headline\":\"STEP Business R&#038;D&#038;I for Digital and Biotechnology\",\"datePublished\":\"2026-01-29T11:56:25+00:00\",\"dateModified\":\"2026-02-23T16:55:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/oportoaccounting.com\/new\/2026\/01\/29\/step-business-rdi-digital-biotechnology\/\"},\"wordCount\":623,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/oportoaccounting.com\/new\/#organization\"},\"image\":{\"@id\":\"https:\/\/oportoaccounting.com\/new\/2026\/01\/29\/step-business-rdi-digital-biotechnology\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/oportoaccounting.com\/new\/wp-content\/uploads\/2026\/01\/2030-1.png\",\"articleSection\":[\"Grants\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/oportoaccounting.com\/new\/2026\/01\/29\/step-business-rdi-digital-biotechnology\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/oportoaccounting.com\/new\/2026\/01\/29\/step-business-rdi-digital-biotechnology\/\",\"url\":\"https:\/\/oportoaccounting.com\/new\/2026\/01\/29\/step-business-rdi-digital-biotechnology\/\",\"name\":\"STEP business R&D&I for digital and biotechnology\",\"isPartOf\":{\"@id\":\"https:\/\/oportoaccounting.com\/new\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/oportoaccounting.com\/new\/2026\/01\/29\/step-business-rdi-digital-biotechnology\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/oportoaccounting.com\/new\/2026\/01\/29\/step-business-rdi-digital-biotechnology\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/oportoaccounting.com\/new\/wp-content\/uploads\/2026\/01\/2030-1.png\",\"datePublished\":\"2026-01-29T11:56:25+00:00\",\"dateModified\":\"2026-02-23T16:55:52+00:00\",\"description\":\"STEP business R&D&I supports integrated R&D and innovation projects in digital, deep-tech and biotechnology sectors.\",\"breadcrumb\":{\"@id\":\"https:\/\/oportoaccounting.com\/new\/2026\/01\/29\/step-business-rdi-digital-biotechnology\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/oportoaccounting.com\/new\/2026\/01\/29\/step-business-rdi-digital-biotechnology\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/oportoaccounting.com\/new\/2026\/01\/29\/step-business-rdi-digital-biotechnology\/#primaryimage\",\"url\":\"https:\/\/oportoaccounting.com\/new\/wp-content\/uploads\/2026\/01\/2030-1.png\",\"contentUrl\":\"https:\/\/oportoaccounting.com\/new\/wp-content\/uploads\/2026\/01\/2030-1.png\",\"width\":970,\"height\":550},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/oportoaccounting.com\/new\/2026\/01\/29\/step-business-rdi-digital-biotechnology\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/oportoaccounting.com\/new\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"STEP Business R&#038;D&#038;I for Digital and Biotechnology\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/oportoaccounting.com\/new\/#website\",\"url\":\"https:\/\/oportoaccounting.com\/new\/\",\"name\":\"Oporto Accounting, your trusted partner in Portugal\",\"description\":\"Registration, Secretarial, Compliance, Tax filling and Accountancy\",\"publisher\":{\"@id\":\"https:\/\/oportoaccounting.com\/new\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/oportoaccounting.com\/new\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/oportoaccounting.com\/new\/#organization\",\"name\":\"Oporto Accounting\",\"url\":\"https:\/\/oportoaccounting.com\/new\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/oportoaccounting.com\/new\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/oportoaccounting.com\/wp-content\/uploads\/2024\/05\/Oporto-Accounting-Logo.webp\",\"contentUrl\":\"https:\/\/oportoaccounting.com\/wp-content\/uploads\/2024\/05\/Oporto-Accounting-Logo.webp\",\"width\":500,\"height\":499,\"caption\":\"Oporto Accounting\"},\"image\":{\"@id\":\"https:\/\/oportoaccounting.com\/new\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/307331302463467\",\"https:\/\/x.com\/OportoAccountin\",\"https:\/\/www.linkedin.com\/company\/oporto-accounting\",\"https:\/\/www.instagram.com\/oportoaccounting\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/oportoaccounting.com\/new\/#\/schema\/person\/7252c4f13da985cd488664b8e798256f\",\"name\":\"marketing@oportoaccounting.eu\",\"url\":\"https:\/\/oportoaccounting.com\/new\/author\/carolinaoportoaccounting-eu\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"STEP business R&D&I for digital and biotechnology","description":"STEP business R&D&I supports integrated R&D and innovation projects in digital, deep-tech and biotechnology sectors.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/oportoaccounting.com\/new\/2026\/01\/29\/step-business-rdi-digital-biotechnology\/","og_locale":"en_US","og_type":"article","og_title":"STEP business R&D&I for digital and biotechnology","og_description":"STEP business R&D&I supports integrated R&D and innovation projects in digital, deep-tech and biotechnology sectors.","og_url":"https:\/\/oportoaccounting.com\/new\/2026\/01\/29\/step-business-rdi-digital-biotechnology\/","og_site_name":"Oporto Accounting","article_publisher":"https:\/\/www.facebook.com\/307331302463467","article_published_time":"2026-01-29T11:56:25+00:00","article_modified_time":"2026-02-23T16:55:52+00:00","og_image":[{"width":970,"height":550,"url":"https:\/\/oportoaccounting.com\/new\/wp-content\/uploads\/2026\/01\/2030-1.png","type":"image\/png"}],"author":"marketing@oportoaccounting.eu","twitter_card":"summary_large_image","twitter_creator":"@OportoAccountin","twitter_site":"@OportoAccountin","twitter_misc":{"Written by":"marketing@oportoaccounting.eu","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/oportoaccounting.com\/new\/2026\/01\/29\/step-business-rdi-digital-biotechnology\/#article","isPartOf":{"@id":"https:\/\/oportoaccounting.com\/new\/2026\/01\/29\/step-business-rdi-digital-biotechnology\/"},"author":{"name":"marketing@oportoaccounting.eu","@id":"https:\/\/oportoaccounting.com\/new\/#\/schema\/person\/7252c4f13da985cd488664b8e798256f"},"headline":"STEP Business R&#038;D&#038;I for Digital and Biotechnology","datePublished":"2026-01-29T11:56:25+00:00","dateModified":"2026-02-23T16:55:52+00:00","mainEntityOfPage":{"@id":"https:\/\/oportoaccounting.com\/new\/2026\/01\/29\/step-business-rdi-digital-biotechnology\/"},"wordCount":623,"commentCount":0,"publisher":{"@id":"https:\/\/oportoaccounting.com\/new\/#organization"},"image":{"@id":"https:\/\/oportoaccounting.com\/new\/2026\/01\/29\/step-business-rdi-digital-biotechnology\/#primaryimage"},"thumbnailUrl":"https:\/\/oportoaccounting.com\/new\/wp-content\/uploads\/2026\/01\/2030-1.png","articleSection":["Grants"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/oportoaccounting.com\/new\/2026\/01\/29\/step-business-rdi-digital-biotechnology\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/oportoaccounting.com\/new\/2026\/01\/29\/step-business-rdi-digital-biotechnology\/","url":"https:\/\/oportoaccounting.com\/new\/2026\/01\/29\/step-business-rdi-digital-biotechnology\/","name":"STEP business R&D&I for digital and biotechnology","isPartOf":{"@id":"https:\/\/oportoaccounting.com\/new\/#website"},"primaryImageOfPage":{"@id":"https:\/\/oportoaccounting.com\/new\/2026\/01\/29\/step-business-rdi-digital-biotechnology\/#primaryimage"},"image":{"@id":"https:\/\/oportoaccounting.com\/new\/2026\/01\/29\/step-business-rdi-digital-biotechnology\/#primaryimage"},"thumbnailUrl":"https:\/\/oportoaccounting.com\/new\/wp-content\/uploads\/2026\/01\/2030-1.png","datePublished":"2026-01-29T11:56:25+00:00","dateModified":"2026-02-23T16:55:52+00:00","description":"STEP business R&D&I supports integrated R&D and innovation projects in digital, deep-tech and biotechnology sectors.","breadcrumb":{"@id":"https:\/\/oportoaccounting.com\/new\/2026\/01\/29\/step-business-rdi-digital-biotechnology\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/oportoaccounting.com\/new\/2026\/01\/29\/step-business-rdi-digital-biotechnology\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/oportoaccounting.com\/new\/2026\/01\/29\/step-business-rdi-digital-biotechnology\/#primaryimage","url":"https:\/\/oportoaccounting.com\/new\/wp-content\/uploads\/2026\/01\/2030-1.png","contentUrl":"https:\/\/oportoaccounting.com\/new\/wp-content\/uploads\/2026\/01\/2030-1.png","width":970,"height":550},{"@type":"BreadcrumbList","@id":"https:\/\/oportoaccounting.com\/new\/2026\/01\/29\/step-business-rdi-digital-biotechnology\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/oportoaccounting.com\/new\/"},{"@type":"ListItem","position":2,"name":"STEP Business R&#038;D&#038;I for Digital and Biotechnology"}]},{"@type":"WebSite","@id":"https:\/\/oportoaccounting.com\/new\/#website","url":"https:\/\/oportoaccounting.com\/new\/","name":"Oporto Accounting, your trusted partner in Portugal","description":"Registration, Secretarial, Compliance, Tax filling and Accountancy","publisher":{"@id":"https:\/\/oportoaccounting.com\/new\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/oportoaccounting.com\/new\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/oportoaccounting.com\/new\/#organization","name":"Oporto Accounting","url":"https:\/\/oportoaccounting.com\/new\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/oportoaccounting.com\/new\/#\/schema\/logo\/image\/","url":"https:\/\/oportoaccounting.com\/wp-content\/uploads\/2024\/05\/Oporto-Accounting-Logo.webp","contentUrl":"https:\/\/oportoaccounting.com\/wp-content\/uploads\/2024\/05\/Oporto-Accounting-Logo.webp","width":500,"height":499,"caption":"Oporto Accounting"},"image":{"@id":"https:\/\/oportoaccounting.com\/new\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/307331302463467","https:\/\/x.com\/OportoAccountin","https:\/\/www.linkedin.com\/company\/oporto-accounting","https:\/\/www.instagram.com\/oportoaccounting\/"]},{"@type":"Person","@id":"https:\/\/oportoaccounting.com\/new\/#\/schema\/person\/7252c4f13da985cd488664b8e798256f","name":"marketing@oportoaccounting.eu","url":"https:\/\/oportoaccounting.com\/new\/author\/carolinaoportoaccounting-eu\/"}]}},"_links":{"self":[{"href":"https:\/\/oportoaccounting.com\/new\/wp-json\/wp\/v2\/posts\/3994","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/oportoaccounting.com\/new\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/oportoaccounting.com\/new\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/oportoaccounting.com\/new\/wp-json\/wp\/v2\/users\/10"}],"replies":[{"embeddable":true,"href":"https:\/\/oportoaccounting.com\/new\/wp-json\/wp\/v2\/comments?post=3994"}],"version-history":[{"count":5,"href":"https:\/\/oportoaccounting.com\/new\/wp-json\/wp\/v2\/posts\/3994\/revisions"}],"predecessor-version":[{"id":4129,"href":"https:\/\/oportoaccounting.com\/new\/wp-json\/wp\/v2\/posts\/3994\/revisions\/4129"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/oportoaccounting.com\/new\/wp-json\/wp\/v2\/media\/3961"}],"wp:attachment":[{"href":"https:\/\/oportoaccounting.com\/new\/wp-json\/wp\/v2\/media?parent=3994"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/oportoaccounting.com\/new\/wp-json\/wp\/v2\/categories?post=3994"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/oportoaccounting.com\/new\/wp-json\/wp\/v2\/tags?post=3994"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}